Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)

7.17 +0.12 (+1.70%) At close: 03:04PM CST

Shanghai RAAS Blood Products Co., Ltd.

No. 2009, Wangyuan Road
Fengxian District
Shanghai 201401
China
86 21 2213 0888
https://www.raas-corp.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 3,254

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jun Xu	GM & Director	N/A	N/A	1964
Mr. Zheng Liu	Deputy General Manager & Secretary of Board of Directors	N/A	N/A	1970
Mr. Ji Hui Shen	Deputy General Manager	N/A	N/A	1966
Mr. Hui Lu	Deputy General Manager	N/A	N/A	1975
Ms. Zhengmin Song	Deputy General Manager	N/A	N/A	1968
Mr. Leqi Chen	Financial Manager	N/A	N/A	1987
Mr. Yang Gu M.D.	Director of Sales & Marketing	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.

Corporate governance

Shanghai RAAS Blood Products Co., Ltd.’s ISS governance QualityScore as of 1 June 2024 is 4. The pillar scores are Audit: 7; Board: 7; Shareholder rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.